Elixirgen Therapeutics, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Baltimore MD United States (2012)

Organization Overview

First Clinical Trial
2020
NCT04211714
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Elixirgen Therapeutics, Inc.